Everyday Health on MSN
Should you take a GLP-1 drug to treat OSA?
Zepbound (tirzepatide) has been approved by the FDA to treat OSA. Find out who may be a good fit for this GLP-1, how it works ...
The American Medical Association reports that about 30 million people in the US live with sleep apnea, but only one-fifth of these cases are clinically diagnosed. That means that many people are ...
The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly’s Zepbound ...
Dec. 21 (UPI) --Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has been approved by the Food and Drug Administration for treating moderate to severe obstructive sleep apnea. The agency ...
Last week, Australia's Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnea, a condition in which breathing stops and starts repeatedly during sleep. The ...
Long Islanders suffering from sleep apnea inundated the sleep center at St. Charles Hospital in Port Jefferson with phone calls earlier this year after the Food and Drug Administration approved ...
The partnership gives patients with both conditions a direct path to care from both clinics.Hamilton, Ontario and Vaughan, Ontario--(Newsfile Corp. - October 1, 2026) - Launchit Solutions Inc.
The FDA also recommends that prescribed users reduce their caloric intake and increase their exercise Shelby Knowles/Bloomberg via Getty The weight loss drug Zepbound, generically known as tirzepatide ...
Nearly 30 million adults in the U.S. have obstructive sleep apnea (OSA)—and many don't even know it. If you've been waking up exhausted or dealing with unexplained headaches, your body might be trying ...
Assistant Professor of Information Technology Shumit Saha has received a National Institutes of Health grant to develop ...
Obstructive sleep apnea has long been dismissed as a noisy nuisance of the night, a condition whose chief casualties are a ...
The FDA has approved Eli Lilly's Zepbound to treat moderate to severe obstructive sleep apnea in adults with obesity. Reading time 3 minutes Many people struggling with apnea will now have a new way ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results